Indian online pharmacy startup PharmEasy, once valued at $5.6 billion, is still about 92% below its peak valuation, according to new estimates by its investor Janus Henderson. According to the British-American global asset firm, which disclosed how it values its shares in the Indian startup in a securities filing, PharmEasy’s implied valuation at the end […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Source : PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates
